Posted: 2 October 2026 - Boston, United States of America
Northeastern University and Alnylam Pharmaceuticals offer a two-year US Market Access fellowship. The fellow will work on payer and reimbursement strategies for RNAi therapeutics, collaborating with multiple teams to ensure alignment across commercial and medical functions. Applicants must have a Doctor of Pharmacy degree and be eligible for licensure in Massachusetts. The application deadline for materials is October 31, 2026, with letters of recommendation due by November 23, 2026.